17+ hour, 56+ min ago   (232+ words) Prostate cancer is the second deadliest cancer in men in the United States. If caught early, prostate cancer is treatable with a 99 percent five-year survival rate. But if caught late and the cancer has spread to other parts of the…...

3+ day, 14+ hour ago   (451+ words) Cancer Metabolism Drives Immune Suppression in Triple Negative Breast Cancer Labroots Cancer Metabolism Drives Immune Suppression in Triple Negative Breast Cancer Bellahcene is a Professor and Director of the National Fund for Scientific Research within the Department of Biomedical and…...

1+ week, 3+ day ago   (233+ words) “Intismeran in combination with pembrolizumab (Keytruda) has the potential to establish a new treatment paradigm in the adjuvant melanoma setting, helping patients remain cancer-free for longer,” she added. The INTerpath-001 trial is a randomized, double-blind, placebo- and active-comparator-controlled global Phase…...

1+ week, 5+ day ago   (93+ words) Attendees will gain practical insights into aligning donor characteristics with specific research, assay development, and manufacturing goals to improve data quality and reduce variability. This webinar will focus on the criticality of: Sourcing: How deeply characterized donor populations and repeat…...

2+ week, 2+ day ago   (261+ words) Immunotherapy has drastically improved outcomes for patients with late-stage melanoma skin cancer, but still 50 percent of patients do not respond to treatment. In a study published in the Journal for ImmunoTherapy of Cancer, researchers analyzed melanoma patients' blood samples to…...

2+ week, 6+ day ago   (59+ words) Bringing innovative therapeutics to market requires faster, smarter clinical development strategies. As R&D investments continue to rise, genetic analysis has become an essential tool for improving trial efficiency, reducing enrollment timelines, and enabling precision medicine. Download this white paper…...

2+ week, 6+ day ago   (65+ words) Bringing innovative therapeutics to market requires faster, smarter clinical development strategies. As R&D investments continue to rise, genetic analysis has become an essential tool for improving trial efficiency, reducing enrollment timelines, and enabling precision medicine. Download this white paper…...

3+ week, 2+ day ago   (163+ words) Earlier this week, the companies released a statement saying that an interim analysis of the phase 3 clinical trial evaluating the efficacy of the personalized mRNA cancer vaccine, intismeran autogene (also known as mRNA-4157 or V940), reduced the risk of recurrence of…...

3+ week, 3+ day ago   (475+ words) Colorectal Cancer Damages Nerves Labroots Colorectal Cancer Damages Nerves Cancer treatment includes an array of different approaches to stop and eliminate tumor progression. While novel therapies are changing the way physicians treat patients, chemotherapy remains the standard-of-care. Unfortunately, chemotherapy causes…...

3+ week, 3+ day ago   (475+ words) Labroots Colorectal Cancer Damages Nerves Cancer treatment includes an array of different approaches to stop and eliminate tumor progression. While novel therapies are changing the way physicians treat patients, chemotherapy remains the standard-of-care. Unfortunately, chemotherapy causes toxicity in patients. Specifically,…...